Eligibility of emergency psychiatry patients for clinical trials studying depression

被引:0
|
作者
Lawrence, Ryan E. [1 ,2 ]
Bernstein, Adam [3 ]
Jaffe, Chaya [4 ]
Zhao, Yinjun [5 ]
Wang, Yuanjia [6 ]
Goldberg, Terry E. [7 ]
机构
[1] Columbia Univ, Dept Psychiat, Med Ctr, New York, NY 10027 USA
[2] Presbyterian Hosp, New York State Psychiat Inst, Comprehens Psychiat Emergency Program New York, 1051 Riverside Dr, New York, NY 10032 USA
[3] Creedmoor Psychiat Ctr, Queens, NY USA
[4] New York State Psychiat Inst & Hosp, New York, NY USA
[5] Columbia Univ, Mailman Sch Publ Hlth, Dept Biostat, New York, NY USA
[6] Columbia Univ, Dept Biostat, New York, NY USA
[7] Columbia Univ, Dept Psychiat, Med Ctr, New York, NY USA
关键词
Depression; Clinical trial; Exclusion criteria; Emergency psychiatry; ANTIDEPRESSANT EFFICACY TRIALS; EXCLUSION CRITERIA; SAMPLES; GENERALIZABILITY; INCLUSION; DISORDER; ALCOHOL;
D O I
10.1016/j.jad.2023.09.010
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Differences often exist between people with depression who are eligible for clinical trials and those seen in clinical practice. The impact of exclusion criteria on eligibility has been previously reported for inpatients and outpatients, but has not been assessed for emergency psychiatry patients; a group that overlaps with inpatients and outpatients but also has important distinctives. Understanding the frequencies of commonly used exclusion criteria in this population could inform interpretation of existing data (generalizability) and highlight opportunities/needs for future trials.Methods: We reviewed 67 clinical trials studying depression using Qualitative Content Analysis to identify common and recurring exclusion criteria. We examined the frequency of these exclusion criteria among a clinical sample of emergency psychiatry patients. Results: Most clinical trials had exclusions for basic research requirements, age, symptom severity, psychosis, and substance use. Applying 9 commonly used exclusion criteria to the clinical population resulted in a 3.3 % eligibility rate (95 % CI 1.2 %-7.0 %). Exclusions for psychosis (85.1 % of trials), substance use (83.6 % of trials), and suicide risk (65.7 % of trials) would likely exclude 93 % of emergency psychiatry patients. The prevalence of psychosis, substance use, and suicide risk was much higher among emergency psychiatry patients than among previously studied populations. Limitations: Some eligibility criteria could not be measured. The Qualitative Content Analysis consolidated similar exclusion criteria, losing potentially important nuances in wordings.Conclusions: Exclusion criteria commonly used in contemporary clinical trials of depression limit generalizability to emergency psychiatry patients, due in large part to exclusions for psychosis, substance use, and suicide risk.
引用
收藏
页码:10 / 15
页数:6
相关论文
共 50 条
  • [31] A systematic review of eligibility criteria for phase II clinical trials for patients with lung cancer
    Doherty, Gary
    Ogunmwonyi, Innocent
    Shotton, Rohan
    BRITISH JOURNAL OF CANCER, 2018, 119 (11) : 46 - 46
  • [32] Clinical Trials Eligibility of Patients With Malignant Pleural Mesothelioma: Use of Novel Therapies and Outcomes
    Lau, Brandon
    Boyer, Michael
    Lee, Jenny H.
    Kao, Steven
    CLINICAL LUNG CANCER, 2020, 21 (04) : 378 - +
  • [33] Early clinical trials in patients with pancreatic cancer: Assessment of factors limiting eligibility and effectiveness
    Kerbage, F.
    Ducreux, M. P.
    Eid, R.
    Boige, V.
    Malka, D.
    Gelli, M.
    Perret, A.
    Smolenschi, C.
    Prieux, C.
    Verlingue, L.
    Martin-Romano, P.
    Massard, C.
    Hollebecque, A.
    ANNALS OF ONCOLOGY, 2020, 31 : S953 - S953
  • [34] Effect of selection of QTc formula on eligibility of cancer patients for phase I clinical trials
    Borad, Mitesh J.
    Soman, Arundhati D.
    Benjamin, Martin
    Casa, Daniel
    Tembe, Waibhav D.
    Piper, Barbara F.
    Ramanathan, Ramesh
    Tibes, Raoul
    Jameson, Gayle
    Ansaldo, Karen
    Von Hoff, Daniel D.
    INVESTIGATIONAL NEW DRUGS, 2013, 31 (04) : 1056 - 1065
  • [35] Effect of selection of QTc formula on eligibility of patients for phase I cancer clinical trials
    Benjamin, M.
    Casa, D.
    Tembe, W.
    Piper, B.
    Anthony, S.
    Ramanathan, R.
    Tibes, R.
    Jameson, G.
    Von Hoff, D.
    Borad, M.
    EJC SUPPLEMENTS, 2008, 6 (12): : 120 - 120
  • [36] Eligibility for clinical trials is unsatisfactory for patients with myelodysplastic syndromes, even at a tertiary referral center
    Nachtkamp, Kathrin
    Stark, Josefine
    Kuendgen, Andrea
    Schroeder, Thomas
    Strupp, Corinna
    Strapatsas, Judith
    Schuler, Esther
    Kaivers, Jennifer
    Giagounidis, Aristoteles
    Rautenberg, Christina
    Aul, Carlo
    Runde, Volker
    Haas, Rainer
    Kobbe, Guido
    Gattermann, Norbert
    Germing, Ulrich
    LEUKEMIA RESEARCH, 2021, 108
  • [37] Effect of selection of QTc formula on eligibility of cancer patients for phase I clinical trials
    Mitesh J. Borad
    Arundhati D. Soman
    Martin Benjamin
    Daniel Casa
    Waibhav D. Tembe
    Barbara F. Piper
    Ramesh Ramanathan
    Raoul Tibes
    Gayle Jameson
    Karen Ansaldo
    Daniel D. Von Hoff
    Investigational New Drugs, 2013, 31 : 1056 - 1065
  • [38] Evaluation of eligibility and recruitment in breast cancer clinical trials
    Lemieux, Julie
    Forget, Genevieve
    Brochu, Olyvia
    Provencher, Louise
    Cantin, Guy
    Desbiens, Christine
    Doyle, Catherine
    Poirier, Brigitte
    Camden, Stephanie
    Durocher, Martin
    BREAST, 2014, 23 (04): : 385 - 392
  • [39] Visual aggregate analysis of eligibility features of clinical trials
    He, Zhe
    Carini, Simona
    Sim, Ida
    Weng, Chunhua
    JOURNAL OF BIOMEDICAL INFORMATICS, 2015, 54 : 241 - 255
  • [40] A Real-Time Automated Patient Screening System for Clinical Trials Eligibility in an Emergency Department: Design and Evaluation
    Ni, Yizhao
    Bermudez, Monica
    Kennebeck, Stephanie
    Liddy-Hicks, Stacey
    Dexheimer, Judith
    JMIR MEDICAL INFORMATICS, 2019, 7 (03)